• Over 15 years of biopharmaceutical development including formulation of drug substance and drug product, drug delivery systems, analytical methods, and drug product manufacturing processes • Expertise in formulation development of monoclonal antibodies, bioconjugates, peptides, fragment antigen-binding based drugs, bispecifics, fusion protein, and cell therapy for ophthalmic, subcutaneous, and intravenous administration • Experienced in leading and managing internal and external teams comprising of members from various functional areas to achieve project goals at defined project timelines • Knowledgeable in quality by design concept of drug development including application in combination products • Proficient in interaction with regulatory agencies in both early and late stages of drug development (IND to BLA filings)
Associate Director, Cell and Gene Therapy Formulation and Fill/Finish at Sangamo Therapeutics, Inc.
Master's degree, Business Administration